advertisement

Topcon

Abstract #18188 Published in IGR 9-2

Viscogonioplasty: an effective procedure for lowering intraocular pressure in primary angle closure glaucoma

Varma D; Baylis O; Wride N; Phelan PS; Fraser SG
Eye 2007; 21: 472-475


PURPOSE: To evaluate the safety and intraocular pressure (IOP) lowering effect of combined phacoemulsification and viscogonioplasty (Phaco-VGP) in managing primary acute closed-angle glaucoma (ACAG) unresponsive to conventional therapy (patent PI). PATIENT AND METHODS: In all, 15 consecutive eyes of patients with refractory ACAG and greater than 270° peripheral anterior synechiae (PAS) underwent VGP. The technique of VGP involved routine phacoemulsification with intraocular lens implantation (Phaco/IOL) under topical anaesthetic. Following IOL implantation a heavy viscoelastic was used to deepen the anterior chamber and then injected near the angle for 360° (without touching the trabecular meshwork) to break the PAS. No surgical instrument was used to physically break the PAS. Upon completion of VGP, automated irrigation with balanced salt solution to remove the viscoelastic was performed. RESULTS: Mean IOP reduced from 52.1 to 14.1 mmHg by Phaco-VGP at 6-months review. 14/15 patients were free of glaucoma medications at 6-month review. All angles showed exposure of the trabecular meshwork over 360° postoperatively without evidence of residual synechiae. No untoward complications were observed in any patient. CONCLUSION: VGP may have a role in controlling IOP effectively and safely in patients with refractory ACAG. It produces a large drop in the IOP and opening of the angle. It is a relatively simple technique to learn and we would recommend its use in the eyes of all patients who have had ACAG and are undergoing cataract extraction.

Dr. D. Varma, Department of Ophthalmology, Sunderland Eye Infirmary, Sunderland, Tyne and Wear, UK


Classification:

12.14.3 Phacoemulsification (Part of: 12 Surgical treatment > 12.14 Combined cataract extraction and glaucoma surgery)



Issue 9-2

Change Issue


advertisement

Oculus